DK1128831T3 - Farmaceutisk moxifloxacinpræparat - Google Patents

Farmaceutisk moxifloxacinpræparat

Info

Publication number: DK1128831T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical; moxifloxacin preparation; preparation; pharmaceutical moxifloxacin; moxifloxacin
Prior art date: 1998-11-10

Application number

DK99955906T

Other languages

English (en)

Inventor

Patrick Bosche

Hans Friedrich Mahler

Claus Weisemann

Original Assignee

Bayer Healthcare Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-10

Filing date

1999-10-29

Publication date

2005-01-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1128831(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-29 Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag

2005-01-17 Application granted granted Critical

2005-01-17 Publication of DK1128831T3 publication Critical patent/DK1128831T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK99955906T 1998-11-10 1999-10-29 Farmaceutisk moxifloxacinpræparat DK1128831T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19855758		1998-11-10
EP99955906A EP1128831B1 (de)	1998-11-10	1999-10-29	Pharmazeutische zubereitung von moxifloxacin

Publications (1)

Publication Number	Publication Date
DK1128831T3 true DK1128831T3 (da)	2005-01-17

Family

ID=7889824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99955906T DK1128831T3 (da)	1998-11-10	1999-10-29	Farmaceutisk moxifloxacinpræparat

Country Status (41)

Country	Link
US (1)	US6610327B1 (da)
EP (1)	EP1128831B1 (da)
JP (1)	JP4809978B2 (da)
KR (1)	KR100650489B1 (da)
CN (1)	CN1149993C (da)
AR (1)	AR021074A1 (da)
AT (1)	ATE279193T1 (da)
AU (1)	AU745282B2 (da)
BG (1)	BG64974B1 (da)
BR (2)	BR9915208A (da)
CA (1)	CA2349161C (da)
CO (1)	CO5070571A1 (da)
CU (1)	CU23260B7 (da)
CZ (1)	CZ292069B6 (da)
DE (1)	DE59910858D1 (da)
DK (1)	DK1128831T3 (da)
EE (1)	EE04418B1 (da)
ES (1)	ES2229786T3 (da)
HK (1)	HK1042245B (da)
HN (1)	HN1999000183A (da)
HR (1)	HRP20010332B1 (da)
HU (1)	HU229065B1 (da)
ID (1)	ID29089A (da)
IL (2)	IL142642A0 (da)
MA (1)	MA26757A1 (da)
MY (1)	MY121114A (da)
NO (1)	NO319342B1 (da)
NZ (1)	NZ511554A (da)
PE (1)	PE20001304A1 (da)
PL (1)	PL194020B1 (da)
PT (1)	PT1128831E (da)
RU (1)	RU2230555C9 (da)
SI (1)	SI1128831T1 (da)
SK (1)	SK283936B6 (da)
SV (1)	SV1999000194A (da)
TR (1)	TR200101310T2 (da)
TW (1)	TW580388B (da)
UA (1)	UA72483C2 (da)
UY (1)	UY25792A1 (da)
WO (1)	WO2000027398A1 (da)
ZA (1)	ZA200103141B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19937116A1 (de) *	1999-08-06	2001-02-08	Bayer Ag	Moxifloxacin Kochsalzformulierung
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
EP1663226A1 (en) *	2003-09-03	2006-06-07	Ranbaxy Laboratories Limited	Pharmaceutical compositions of moxifloxacin and processes for their preparation
WO2006015545A1 (fr) *	2004-08-11	2006-02-16	Shenzhen Tys R & D Co., Ltd.	Capsule de gelatine de moxifloxacin et procede pour sa preparation
CN1330306C (zh) *	2004-08-11	2007-08-08	深圳市天一时科技开发有限公司	莫西沙星明胶胶囊剂及其制备方法
CN100363001C (zh) *	2005-09-21	2008-01-23	深圳市天一时科技开发有限公司	一种莫西沙星胶囊剂及其制备方法
WO2007033515A1 (fr) *	2005-09-21	2007-03-29	Shenzhen Tys R & D Co., Ltd.	Formulation orale contenant de la moxifloxacine et son procédé de préparation
WO2007033522A1 (fr) *	2005-09-21	2007-03-29	Shenzhen Tys R & D Co., Ltd.	Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
US8314122B2 (en) *	2008-10-09	2012-11-20	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Using of organic solvents in wet granulation of moxifloxacin
US20110293717A1 (en)	2008-12-08	2011-12-01	Ratiopharm Gmbh	Compacted moxifloxacin
TR200907227A2 (tr) *	2009-09-18	2011-04-21	Bi̇lgi̇ç Mahmut	Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) *	2009-11-16	2013-09-11	江苏亚邦强生药业有限公司	莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) *	2010-01-12	2011-07-21	Msn Laboratories Limited	Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) *	2010-06-11	2011-11-23	北京润德康医药技术有限公司	一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) *	2011-01-12	2011-11-23	北京润德康医药技术有限公司	一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) *	2011-04-11	2012-10-17	Innocoll Technologies Limited	Methods for treating bacterial infection
MX2011004759A (es)	2011-05-04	2012-11-21	Senosiain S A De C V Lab	Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) *	2011-10-14	2012-11-20	Закрытое акционерное общество "Брынцалов-А"	Фармацевтический препарат моксифлоксацина
US9675582B2 (en)	2011-10-25	2017-06-13	U.S. Phytotherapy, Inc.	Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
WO2013063271A1 (en) *	2011-10-25	2013-05-02	U.S. Phytotherapy, Inc.	Artemisinin and berberine compositions and methods of making
CA2853701A1 (en)	2011-10-25	2013-05-02	U.S. Phytotherapy, Inc.	Artemisinin and berberine compositions and methods of making
US9358261B2 (en)	2011-10-25	2016-06-07	U.S. Phytotherapy, Inc.	Additional artemisinin and berberine compositions and methods of making
BR112014012994A2 (pt) *	2011-11-30	2017-06-13	Toyama Chemical Co Ltd	tablete contendo hidrato de metanossulfonato do ácido 1-ciclopropil-8-(difluorometóxi)-7-[(1r)-1-metil-2,3-diidro-1h-isoindol-5-il]-4-oxo-1, 4-diidroquinolina-3-carboxílico
BRPI1106900A2 (pt)	2011-12-26	2013-11-05	Ems Sa	Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) *	2012-02-21	2012-07-04	天津市汉康医药生物技术有限公司	一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) *	2012-04-11	2013-06-05	南京优科生物医药有限公司	一种莫西沙星片剂及其制备方法
FR2992218B1 (fr)	2012-06-22	2015-01-23	Rivopharm Sa	Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) *	2012-10-19	2016-04-20	深圳信立泰药业股份有限公司	一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) *	2013-02-07	2015-08-20	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")	Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) *	2013-12-20	2015-06-25	씨제이헬스케어 주식회사	목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) *	2014-05-22	2015-08-10	Открытое Акционерное Общество "Татхимфармпрепараты"	Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3601566A1 (de) *	1986-01-21	1987-07-23	Bayer Ag	Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en)	1986-01-21	1994-02-15	Bayer Aktiengesellschaft	Pharmaceutical formulations of ciprofloxacin
JPH01175936A (ja) *	1987-12-28	1989-07-12	Kyorin Pharmaceut Co Ltd	６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
DE3906365A1 (de)	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
TW209865B (da) *	1992-01-10	1993-07-21	Bayer Ag
DE19546249A1 (de) *	1995-12-12	1997-06-19	Bayer Ag	Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) *	1998-01-21	2000-09-29	Pfizer Prod Inc	Comprimido de mesilato de trovafloxacino

1999
- 1999-10-29 UA UA2001063872A patent/UA72483C2/uk unknown
- 1999-10-29 NZ NZ511554A patent/NZ511554A/en not_active IP Right Cessation
- 1999-10-29 KR KR1020017005833A patent/KR100650489B1/ko active IP Right Grant
- 1999-10-29 BR BR9915208-8A patent/BR9915208A/pt not_active IP Right Cessation
- 1999-10-29 ID IDW00200101040A patent/ID29089A/id unknown
- 1999-10-29 AU AU12674/00A patent/AU745282B2/en not_active Expired
- 1999-10-29 JP JP2000580627A patent/JP4809978B2/ja not_active Expired - Lifetime
- 1999-10-29 PL PL99348112A patent/PL194020B1/pl unknown
- 1999-10-29 IL IL14264299A patent/IL142642A0/xx active IP Right Grant
- 1999-10-29 BR BRPI9915208-8 patent/BRPI9915208B8/pt unknown
- 1999-10-29 CN CNB998131245A patent/CN1149993C/zh not_active Expired - Lifetime
- 1999-10-29 AT AT99955906T patent/ATE279193T1/de active
- 1999-10-29 CZ CZ20011652A patent/CZ292069B6/cs not_active IP Right Cessation
- 1999-10-29 ES ES99955906T patent/ES2229786T3/es not_active Expired - Lifetime
- 1999-10-29 US US09/830,770 patent/US6610327B1/en not_active Expired - Lifetime
- 1999-10-29 PT PT99955906T patent/PT1128831E/pt unknown
- 1999-10-29 HU HU0104762A patent/HU229065B1/hu unknown
- 1999-10-29 SI SI9930706T patent/SI1128831T1/xx unknown
- 1999-10-29 TR TR2001/01310T patent/TR200101310T2/xx unknown
- 1999-10-29 SK SK610-2001A patent/SK283936B6/sk not_active IP Right Cessation
- 1999-10-29 DE DE1999510858 patent/DE59910858D1/de not_active Expired - Lifetime
- 1999-10-29 CA CA002349161A patent/CA2349161C/en not_active Expired - Lifetime
- 1999-10-29 EP EP99955906A patent/EP1128831B1/de not_active Expired - Lifetime
- 1999-10-29 EE EEP200100259A patent/EE04418B1/xx unknown
- 1999-10-29 RU RU2001116096/15A patent/RU2230555C9/ru active
- 1999-10-29 DK DK99955906T patent/DK1128831T3/da active
- 1999-10-29 WO PCT/EP1999/008230 patent/WO2000027398A1/de active IP Right Grant
- 1999-11-01 HN HN1999000183A patent/HN1999000183A/es unknown
- 1999-11-03 AR ARP990105567A patent/AR021074A1/es active IP Right Grant
- 1999-11-04 TW TW088119183A patent/TW580388B/zh not_active IP Right Cessation
- 1999-11-05 MY MYPI99004825A patent/MY121114A/en unknown
- 1999-11-08 UY UY25792A patent/UY25792A1/es not_active Application Discontinuation
- 1999-11-09 CO CO99070667A patent/CO5070571A1/es unknown
- 1999-11-09 PE PE1999001134A patent/PE20001304A1/es not_active IP Right Cessation
- 1999-11-10 SV SV1999000194A patent/SV1999000194A/es active IP Right Grant
2001
- 2001-04-17 IL IL142642A patent/IL142642A/en not_active IP Right Cessation
- 2001-04-18 ZA ZA200103141A patent/ZA200103141B/en unknown
- 2001-04-20 BG BG105459A patent/BG64974B1/bg unknown
- 2001-05-07 NO NO20012248A patent/NO319342B1/no not_active IP Right Cessation
- 2001-05-10 CU CU20010114A patent/CU23260B7/es unknown
- 2001-05-10 MA MA26189A patent/MA26757A1/fr unknown
- 2001-05-10 HR HR20010332A patent/HRP20010332B1/xx not_active IP Right Cessation
2002
- 2002-05-29 HK HK02104010.6A patent/HK1042245B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ20011652A3 (cs)	2001-08-15
NO319342B1 (no)	2005-07-18
PL348112A1 (en)	2002-05-06
PL194020B1 (pl)	2007-04-30
HK1042245B (zh)	2005-03-11
WO2000027398A1 (de)	2000-05-18
BRPI9915208A (pt)	2001-07-31
BRPI9915208B1 (pt)	2011-11-01
NZ511554A (en)	2003-07-25
MY121114A (en)	2005-12-30
HN1999000183A (es)	1999-11-01
RU2230555C2 (ru)	2004-06-20
HU229065B1 (en)	2013-07-29
ES2229786T3 (es)	2005-04-16
JP2002529415A (ja)	2002-09-10
PE20001304A1 (es)	2000-12-30
UA72483C2 (en)	2005-03-15
HK1042245A1 (en)	2002-08-09
SI1128831T1 (en)	2005-04-30
HRP20010332B1 (en)	2011-01-31
US6610327B1 (en)	2003-08-26
EE200100259A (et)	2002-12-16
CA2349161C (en)	2008-01-29
ATE279193T1 (de)	2004-10-15
ZA200103141B (en)	2002-05-07
BG64974B1 (bg)	2006-11-30
BG105459A (en)	2001-12-29
JP4809978B2 (ja)	2011-11-09
EP1128831A1 (de)	2001-09-05
CZ292069B6 (cs)	2003-07-16
ID29089A (id)	2001-07-26
KR100650489B1 (ko)	2006-11-28
DE59910858D1 (de)	2004-11-18
NO20012248D0 (no)	2001-05-07
PT1128831E (pt)	2005-01-31
SK283936B6 (sk)	2004-05-04
IL142642A0 (en)	2002-03-10
EE04418B1 (et)	2005-02-15
EP1128831B1 (de)	2004-10-13
TW580388B (en)	2004-03-21
AU1267400A (en)	2000-05-29
CN1325306A (zh)	2001-12-05
IL142642A (en)	2006-10-05
SK6102001A3 (en)	2001-12-03
TR200101310T2 (tr)	2001-10-22
NO20012248L (no)	2001-06-06
KR20010089424A (ko)	2001-10-06
BR9915208A (pt)	2001-07-31
CU23260B7 (es)	2008-01-24
AR021074A1 (es)	2002-06-12
HRP20010332A2 (en)	2002-06-30
SV1999000194A (es)	2000-10-16
RU2230555C9 (ru)	2006-02-27
HUP0104762A3 (en)	2002-10-28
HUP0104762A2 (hu)	2002-05-29
BRPI9915208B8 (pt)	2021-07-06
MA26757A1 (fr)	2004-12-20
UY25792A1 (es)	2001-08-27
AU745282B2 (en)	2002-03-21
CN1149993C (zh)	2004-05-19
CO5070571A1 (es)	2001-08-28
CA2349161A1 (en)	2000-05-18

Publication	Publication Date	Title
DK1128831T3 (da)	2005-01-17	Farmaceutisk moxifloxacinpræparat
NO20005218D0 (no)	2000-10-17	Farmasøytisk aerosolpreparat
NO992339D0 (no)	1999-05-14	Farmas°ytiske formuleringer
NO20015175D0 (no)	2001-10-23	Farmasöytisk sammensetning
FI991485A (fi)	2000-12-31	Uusi farmaseuttinen koostumus
NO20012915D0 (no)	2001-06-13	Ny farmasöytisk formulering
ID27415A (id)	2001-04-05	Komposisi farmaseutik
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
NO20005399L (no)	2000-10-26	Farmasöytisk preparat
PT1200092E (pt)	2004-07-30	Farmacos de beta-carbolina
NO20022606L (no)	2002-07-11	Farmasöytiske kombinasjoner
ID27201A (id)	2001-03-08	Komposisi farmasi
NO20014926D0 (no)	2001-10-10	Farmasöytiske forbindelser
ID30032A (id)	2001-11-01	Formulasi farmasi
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
NO20016430L (no)	2002-02-26	Farmasöytisk kompleks
DE69906934D1 (de)	2003-05-22	Arzneizubereitungen
NO20004816D0 (no)	2000-09-26	Ny farmasøytisk formulering
NO20021036L (no)	2002-04-26	Farmasöytisk preparat
SE9803952D0 (sv)	1998-11-18	Pharmaceutical formulation
FI3862U1 (fi)	1999-03-18	Geelimuotoinen farmaseuttinen valmiste